Definitive Contract 36C24524C0060
- Not listed
- Cepheid has been awarded a firm fixed-price delivery order valued at $40,704.72 by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, with an ultimate completion date of May 31, 2025, is for molecular diagnostic solutions to be delivered and performed in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of advanced diagnostic systems and testing solutions to the...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2.27 million firm fixed-price purchase order by the Department of Veterans Affairs through Veterans Integrated Service Network 20 for the lease and purchase of a molecular diagnostic testing system along with instrument-specific assays. The contract, awarded on August 1, 2022, with an ultimate completion date of July 31, 2027, carries no set-aside designation and represents part of the VA's broader reliance on Cepheid as a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a Blanket Purchase Agreement (BPA) call valued at $422,727.63 by Veterans Integrated Service Network 2, a civilian component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on October 18, 2024, with an ultimate completion date of October 17, 2025, represents a delivery order under an existing BPA vehicle and continues Cepheid's role as a primary federal supplier of...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a Blanket Purchase Agreement (BPA) call valued at $1.87M by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19), with an award date of October 1, 2024, and ultimate completion by September 30, 2025. This firm fixed-price procurement, which utilized no set-aside designation, is issued under the General Services Administration's Multiple Award Schedule (MAS) contracting vehicle. Cepheid will...
- Cepheid Inc. was awarded a $306,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) on October 1, 2025, for the supply of Cepheid testing kits. The contract carries an ultimate completion date of March 31, 2026, with no set-aside designation. As a molecular diagnostics manufacturer headquartered in Sunnyvale, California, Cepheid supplies the federal healthcare system with advanced diagnostic solutions, particularly its...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, received a BPA (Blanket Purchase Agreement) call award from the Department of Veterans Affairs' Veterans Integrated Service Network 19 on November 3, 2023. This firm fixed-price contract, valued at $898,752.40, is scheduled for completion by November 2, 2025, and carries no set-aside designation. The award falls under the General Services Administration's Multiple Award Schedule (MAS) and represents a...
- Cepheid Inc. was awarded a firm fixed-price purchase order valued at $570,182.92 by Veterans Integrated Service Network 6 (VISN 6), a civilian component of the Department of Veterans Affairs, for Cepheid service contract and service agreement work. The contract was awarded on February 10, 2023, with an ultimate completion date of February 9, 2027, and the place of performance is located in Fayetteville, North Carolina. This award carries no set-aside designation and represents a continuation...
- The U.S. Department of Veterans Affairs (VA) has awarded a Delivery Order contract worth $1,007,319.09 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, which has a completion date of September 30, 2024, is for the provision of Cepheid's molecular testing products, including tests for infectious diseases and genetic conditions. This Delivery Order is part of a larger Indefinite Delivery Vehicle (IDV) contract between Cepheid and the VA's Veterans Integrated...
- Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was awarded a $119,554.30 firm-fixed-price purchase order contract by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 6. The contract is to provide reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. The contract was awarded on a sole-source basis, as Cepheid is the sole distributor and manufacturer of the...
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a definitive firm fixed-price contract valued at $892,066.93 by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on March 23, 2024, with an ultimate completion date of March 22, 2029. The contract, which carries no set-aside designation, is to be performed in Baltimore, Maryland. This award represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic solutions, particularly for infectious disease detection and clinical laboratory support across the VA healthcare system. The contract award is consistent with Cepheid's extensive federal contracting history with the Department of Veterans Affairs, which includes two significant Indefinite Delivery Contracts—a $6.74 million agreement with VISN 17 and a substantially larger $32.8 million contract with VISN 6 extending through September 2030. Cepheid's federal portfolio encompasses the provision of GeneXpert diagnostic platform reagents, test cartridges, molecular diagnostic testing systems, and associated maintenance services to support clinical laboratory operations across multiple VA medical centers and integrated service networks. The company's offerings include diagnostic solutions for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases critical to veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $187.3k | 1/29/26 | |
| P00001 | Exercise an Option | $187.3k | 1/8/25 | |
| Not listed | Not listed | $142.9k | 3/19/24 |